Clinical update on nursing home medicine: 2013

Journal of the American Medical Directors Association

Volumn 14, Issue 12, 2013, Pages 860-876

  Messinger Rapport, Barbara J ^a   Gammack, Julie K ^b   Thomas, David R ^b   Morley, John E ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anorexia; Antiresorptive drugs; Behavioral symptoms; Bisphosphonates; Cachexia; Dementia; Depression; Exercise; Hip fracture; Hypertension; Orthostatic hypotension; Pain; Psychological symptoms; Sarcopenia; Undernutrition

Indexed keywords

ANABOLIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CANNABINOID; CORTICOSTEROID; CYPROHEPTADINE; DENOSUMAB; GROWTH HORMONE; MEGESTROL ACETATE; PLACEBO; PLATELET DERIVED GROWTH FACTOR; PRASTERONE;

ANALGESIA; ANOREXIA; ARTICLE; BED REST; BEHAVIOR DISORDER; CACHEXIA; CLINICAL EXAMINATION; COGNITIVE THERAPY; COMPRESSION STOCKING; DEMENTIA; DEPRESSION; DIET SUPPLEMENTATION; DIFFERENTIAL DIAGNOSIS; ENTERIC FEEDING; EXERCISE; GROUP THERAPY; HIP FRACTURE; HUMAN; HYPERTENSION; LASER SURGERY; LEG COMPRESSION; LEG ULCER; MALNUTRITION; MEDICAL CARE; MENTAL DISEASE; META ANALYSIS (TOPIC); NURSING HOME; NURSING HOME CARE; OCCUPATIONAL THERAPY; ORTHOSTATIC HYPOTENSION; PAIN ASSESSMENT; PHYSIOTHERAPY; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESISTANCE TRAINING; SARCOPENIA; SKIN TRANSPLANTATION; STARVATION; SYSTEMATIC REVIEW (TOPIC); VENOUS STASIS; WEIGHT GAIN; WEIGHT REDUCTION; WOUND DRESSING;

ANOREXIA; ANTIRESORPTIVE DRUGS; BEHAVIORAL SYMPTOMS; BISPHOSPHONATES; CACHEXIA; DEMENTIA; DEPRESSION; EXERCISE; HIP FRACTURE; HYPERTENSION; ORTHOSTATIC HYPOTENSION; PAIN; PSYCHOLOGICAL SYMPTOMS; SARCOPENIA; UNDERNUTRITION;

AGED; AGED, 80 AND OVER; ANABOLIC AGENTS; ANOREXIA; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; BANDAGES; BONE DENSITY CONSERVATION AGENTS; CACHEXIA; CONGRESSES AS TOPIC; DEMENTIA; DEPRESSION; DIET, SODIUM-RESTRICTED; FRAIL ELDERLY; GERIATRICS; HIP FRACTURES; HUMAN GROWTH HORMONE; HUMANS; HYPERTENSION; MALNUTRITION; NURSING HOMES; OSTEOPOROTIC FRACTURES; PAIN MANAGEMENT; POSTOPERATIVE CARE; SARCOPENIA; SKIN TRANSPLANTATION; STOCKINGS, COMPRESSION; VARICOSE ULCER; WEIGHT LOSS;

EID: 84896995938     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2013.09.015     Document Type: Article

References (283)

1. National Osteoporosis Foundation. 2013 Clinician's Guide to Prevention and Treatment of Osteoporosis. Available at: Accessed October 19, 2013. http://nof.org/files/nof/public/content/resource/913/files/580.pdf.
2. Boonen S., Eastell R., Su G., et al. Time to onset of antifracture efficacy and year-by-year persistence of effect of zoledronic acid in women with osteoporosis. JBone Miner Res 2012, 27:1487-1493.
3. Lyles K.W., Colon-Emeric C.S., Magaziner J.S., et al. Zoledronic acid and clinical fractures and mortality after hip fracture. NEngl J Med 2007, 357:1799-1809.
4. Reginster J.Y. Antifracture efficacy of currently available therapies for postmenopausal osteoporosis. Drugs 2011, 71:65-78.
5. 2004 National Nursing Home Survey, Residents, table13. June 8, 2008; Available at: Accessed June 8,2013. http://www.cdc.gov/nchs/data/nnhsd/Estimates/nnhs/Estimates_PaymentSource_Tables.pdf.
6. Kennel K.A., Drake M.T. Adverse effects of bisphosphonates: Implications for osteoporosis management. Mayo Clin Proc 2009, 84:632-637. quiz 638.
7. Food and Drug Administration. Background document for meeting of Advisory Committee for Reproductive Health Drugs and Drug Safety and risk Management Advisory Committee. September 9 2011.
8. Jamal S.A., Ljunggren O., Stehman-Breen C., et al. Effects of denosumab on fracture and bone mineral density by level of kidney function. JBone Miner Res 2011, 26:1829-1835.
9. Sivolella S., Lumachi F., Stellini E., Favero L. Denosumab and anti-angiogenetic drug-related osteonecrosis of the jaw: An uncommon but potentially severe disease. Anticancer Res. 2013, 33:1793-1797.
10. Shane E., Burr D., Abrahamsen B., et al. Atypical subtrochanteric and diaphyseal femoral fractures: Second report of a task force of the American society for bone and mineral research. JBone Miner Res 2013, [Epub ahead of print].
11. Morley JE. Osteoporosis and fragility fractures. J Am Med Dir Assoc 12:389-392.
12. Markman L.H., Allison M.B., Rosenberg Z.S., et al. Aretrospective review of patients with atypical femoral fractures while on long-term bisphosphonates: Including pertinent biochemical and imaging studies. Endocr Pract 2013, 19:456-461.
13. Schilcher J., Michaelsson K., Aspenberg P. Bisphosphonate use and atypical fractures of the femoral shaft. NEngl J Med 2011, 364:1728-1737.
14. Black D.M., Schwartz A.V., Ensrud K.E., et al. Effects of continuing or stopping alendronate after 5 years of treatment: The Fracture Intervention Trial Long-term Extension (FLEX): A randomized trial. JAMA 2006, 296:2927-2938.
15. Black D.M., Reid I.R., Boonen S., et al. The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). JBone Miner Res 2012, 27:243-254.
16. Schwartz A.V., Bauer D.C., Cummings S.R., et al. Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: The FLEX trial. JBone Miner Res 2010, 25:976-982.
17. Fink H.A., Milavetz D.L., Palermo L., et al. What proportion of incident radiographic vertebral deformities is clinically diagnosed and vice versa?. JBone Miner Res 2005, 20:1216-1222.
18. Ott S.M. What is the optimal duration of bisphosphonate therapy?. Cleve Clin J Med 2011, 78:619-630.
19. Hellstein J.W., Adler R.A., Edwards B., et al. Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: Executive summary of recommendations from the American Dental Association Council on Scientific Affairs. JAm Dent Assoc 2011, 142:1243-1251.
20. Anonymous Summary of the Updated American Geriatrics Society/British Geriatrics Society clinical practice guideline for prevention of falls in older persons. JAm Geriatr Soc 2011, 59:148-157.
21. Caffrey C. Potentially preventable emergency department visits by nursing home residents: United States, 2004. NCHS Data Brief 2010, 1-8.
22. Yang Y.X., Lewis J.D., Epstein S., Metz D.C. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 2006, 296:2947-2953.
23. Abrahamsen B., Eiken P., Eastell R. Proton pump inhibitor use and the antifracture efficacy of alendronate. Arch Int Med 2011, 171:998-1004.
24. Haney E.M., Chan B.K.S., Diem S.J., et al. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Int Med 2007, 167:1246-1251.
25. Diem S.J., Blackwell T.L., Stone K.L., et al. Use of antidepressants and rates of hip bone loss in older women: The study of osteoporotic fractures. Arch Int Med 2007, 167:1240-1245.
26. Richards J.B., Papaioannou A., Adachi J.D., et al. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Int Med 2007, 167:188-194.
27. Beniczky S.A., Viken J., Jensen L.T., Andersen N.B. Bone mineral density in adult patients treated with various antiepileptic drugs. Seizure 2012, 21:471-472.
28. Gill S.S., Anderson G.M., Fischer H.D., et al. Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: A population-based cohort study. Arch Int Med 2009, 169:867-873.
29. Kim D.H., Brown R.T., Ding E.L., et al. Dementia medications and risk of falls, syncope, and related adverse events: Meta-analysis of randomized controlled trials. JAm Geriatr Soc 2011, 59:1019-1031.
30. Schwartz A.V., Vittinghoff E., Sellmeyer D.E., et al. Diabetes-related complications, glycemic control, and falls in older adults. Diabetes Care 2008, 31:391-396.
31. Passant U., Warkentin S., Gustafson L. Orthostatic hypotension and low blood pressure in organic dementia: A study of prevalence and related clinical characteristics. Int J Geriatr Psychiatry 1997, 12:395-403.
32. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program. JAMA 1991, 265:3255-3264. SHEP Cooperative Research Group.
33. Staessen J.A., Fagard R., Thijs L., et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997, 350:757-764.
34. Beckett N.S., Peters R., Fletcher A.E., et al. Treatment of hypertension in patients 80 years of age or older. NEngl J Med 2008, 358:1887-1898.
35. Chobanian A.V., Bakris G.L., Black H.R., et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003, 289:2560-2571.
36. Denardo S.J., Gong Y., Nichols W.W., et al. Blood pressure and outcomes in very old hypertensive coronary artery disease patients: An INVEST substudy. Am J Med 2010, 123:719-726.
37. Aronow W.S., Fleg J.L., Pepine C.J., et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. JAm Soc Hypertens 2011, 5:259-352.
38. Hackam D.G., Quinn R.R., Ravani P., et al. The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol 2013, 29:528-542.
39. Effects of combination lipid therapy in type 2 diabetes mellitus. NEngl J Med 2010, 362:1563-1574. The ACCORD Study Group.
40. Appel L.J., Wright J.T., Greene T., et al. Intensive blood-pressure control in hypertensive chronic kidney disease. NEngl J Med 2010, 363:918-929.
41. Dietary Guidelines for Americans, 2010 December 2010, U.S. Department of Agriculture and U.S. Department of Health and Human Services, U.S. Government Printing Office: USDA, Washington, DC. 7th ed.
42. Appel L.J., Espeland M.A., Easter L., et al. Effects of reduced sodium intake on hypertension control in older individuals: Results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE). Arch Intern Med 2001, 161:685-693.
43. Appel L.J., Moore T.J., Obarzanek E., et al. Aclinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. NEngl J Med 1997, 336:1117-1124.
44. Cook N.R., Cutler J.A., Obarzanek E., et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: Observational follow-up of the trials of hypertension prevention (TOHP). BMJ 2007, 334:885-888.
45. Cook N.R., Obarzanek E., Cutler J.A., et al. Joint effects of sodium and potassium intake on subsequent cardiovascular disease: The Trials of Hypertension Prevention follow-up study. Arch Intern Med 2009, 169:32-40.
46. Bray G.A., Vollmer W.M., Sacks F.M., et al. Afurther subgroup analysis of the effects of the DASH diet and three dietary sodium levels on blood pressure: Results of the DASH-Sodium Trial. Am J Cardiol 2004, 94:222-227.
47. Graudal N.A., Hubeck-Graudal T., Jurgens G. Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane Review). Am J Hypertens 2012, 25:1-15.
48. Masaki K.H., Schatz I.J., Burchfiel C.M., et al. Orthostatic hypotension predicts mortality in elderly men: The Honolulu Heart Program. Circulation 1998, 98:2290-2295.
49. Passant U., Warkentin S., Karlson S., et al. Orthostatic hypotension in organic dementia: Relationship between blood pressure, cortical blood flow and symptoms. Clin Auton Res 1996, 6:29-36.
50. Beaupre L.A., Jones C.A., Johnston D.W., et al. Recovery of function following a hip fracture in geriatric ambulatory persons living in nursing homes: Prospective cohort study. JAm Geriatr Soc 2012, 60:1268-1273.
51. Sylliaas H., Brovold T., Wyller T.B., et al. Prolonged strength training in older patients after hip fracture: A randomised controlled trial. Age Ageing 2012, 41:206-212.
52. Sylliaas H., Brovold T., Wyller T.B., et al. Progressive strength training in older patients after hip fracture: A randomised controlled trial. Age Ageing 2011, 40:221-227.
53. Singh N.A., Quine S., Clemson L.M., et al. Effects of high-intensity progressive resistance training and targeted multidisciplinary treatment of frailty on mortality and nursing home admissions after hip fracture: A randomized controlled trial. JAm Med Dir Assoc 2012, 13:24-30.
54. Aronow H.U., Sharkey P., Siebens H.C., et al. Initial recovery trajectories among patients with hip fracture: A conceptual approach to exploring comparative effectiveness in postacute care. PM R 2012, 4:264-272.
55. Shyu Y.I., Tsai W.C., Chen M.C., et al. Two-year effects of an interdisciplinary intervention on recovery following hip fracture in older Taiwanese with cognitive impairment. Int J Geriatr Psychiatry 2012, 27:529-538.
56. Munin M.C., Putman K., Hsieh C., et al. Analysis of rehabilitation activities within skilled nursing and inpatient rehabilitation facilities after hip replacement for acute hip fracture. Am J Phys Med Rehabil 2010, 89:530-540.
57. Tian W., DeJong G., Horn S.D., et al. Efficient rehabilitation care for joint replacement patients: Skilled nursing facility or inpatient rehabilitation facility?. Med Decis Making 2012, 32:176-187.
58. Tsaih P.L., Shih Y.L., Hu M.H. Low-intensity task-oriented exercise for ambulation-challenged residents in long term care facilities: A randomized, controlled trial. Am J Phys Med Rehabil 2012, 91:616-624.
59. Serra-Rexach J.A., Bustamante-Ara N., Villarán M.H., et al. Short-term, light- tomoderate-intensity exercise training improves leg muscle strength in theoldest old: A randomized controlled trial. JAm Geriatr Soc 2011, 59:594-602.
60. Valenzuela T. Efficacy of progressive resistance training interventions in older adults in nursing homes: A systematic review. JAm Med Dir Assoc 2012, 13:418-428.
61. Crocker T., Forster A., Young J., et al. Physical rehabilitation for older people in long term care. Cochrane Database Syst Rev 2013, 2:CD004294.
62. Gaboda D., Lucas J., Siegel M., et al. No longer undertreated? Depression diagnosis and antidepressant therapy in elderly long-stay nursing home residents, 1999 to 2007. JAm Geriatr Soc 2011, 59:673-680.
63. Luppa M., Sikorski C., Luck T., et al. Age- and gender-specific prevalence of depression in latest-life-systematic review and meta-analysis. JAffect Disord 2012, 136:212-221.
64. Seitz D., Purandare N., Conn D. Prevalence of psychiatric disorders among older adults in long term care homes: A systematic review. Int Psychogeriatr 2010, 22:1025-1039.
65. Mitchell A.J., Bird V., Rizzo M., et al. Which version of the geriatric depression scale is most useful in medical settings and nursing homes? Diagnostic validity meta-analysis. Am J Geriatr Psychiatry 2010, 18:1066-1077.
66. Prado-Jean A., Couratier P., Bénissan-Tevi L.A., et al. Development and validation of an instrument to detect depression in nursing homes. Nursing homes short depression inventory (NH-SDI). Int J Geriatr Psychiatry 2011, 26:853-859.
67. Cinamon J.S., Finch L., Miller S., et al. Preliminary evidence for the development of a stroke specific geriatric depression scale. Int J Geriatr Psychiatry 2011, 26:188-198.
68. Saliba D., DiFilippo S., Edelen M.O., et al. Testing the PHQ-9 interview and observational versions (PHQ-9 OV) for MDS 3.0. JAm Med Dir Assoc 2012, 13:618-625.
69. Lamers F., Jonkers C.C., Bosma H., et al. Summed score of the Patient Health Questionnaire-9 was a reliable and valid method for depression screening in chronically ill elderly patients. JClin Epidemiol 2008, 61:679-687.
70. Banerjee S., Hellier J., Dewey M., et al. Sertraline or mirtazapine for depression in dementia (HTA-SADD): A randomised, multicentre, double-blind, placebo-controlled trial. Lancet 2011, 378:403-411.
71. Tedeschini E., Levkovitz Y., Iovieno N., et al. Efficacy of antidepressants for late-life depression: A meta-analysis and meta-regression of placebo-controlled randomized trials. JClin Psychiatry 2011, 72:1660-1668.
72. Nelson J.C., Devanand D.P. Asystematic review and meta-analysis of placebo-controlled antidepressant studies in people with depression and dementia. JAm Geriatr Soc 2011, 59:577-585.
73. Wilkinson P., Izmeth Z. Continuation and maintenance treatments for depression in older people. Cochrane Database Syst Rev 2012, 11:CD006727.
74. Kok R.M., Heeren T.J., Nolen W.A. Continuing treatment of depression in the elderly: A systematic review and meta-analysis of double-blinded randomized controlled trials with antidepressants. Am J Geriatr Psychiatry 2011, 19:249-255.
75. Bridle C., Spanjers K., Patel S., et al. Effect of exercise on depression severity in older people: Systematic review and meta-analysis of randomised controlled trials. Br J Psychiatry 2012, 201:180-185.
76. Wallace J.I., Schwartz R.S., LaCroix A.Z., et al. Involuntary weight loss in older outpatients: Incidence and clinical significance. JAm Geriatr Soc 1995, 43:329-337.
77. Murden R.A., Ainslie N.K. Recent weight loss is related to short-term mortality in nursing homes. JGen Int Med 2004, 9:648-650.
78. Ryan C., Bryant E., Eleazer P., et al. Unintentional weight loss in long term care: Predictor of mortality in the elderly. Southern Med J 1995, 88:721-724.
79. Sullivan D.H., Johnson L.E., Bopp M.M., Roberson P.K. Prognostic significance of monthly weight fluctuations among older nursing home residents. JGeront A Biol Sci Med Sci 2004, 59:M633-M639.
80. Long Term Care Facility Resident Assessment Instrument (RAI) User's Manual 1999, Eliot Press, Natick, MA.
81. Launer L.J., Harris L.T., Rumpel C., Madans J. Body mass index, weight change and risk of mobility disability in middle-aged and older women. JAMA 1994, 271:1083-1098.
82. Zuliani G., Romagnoni F., Valpato S., et al. Nutritional parameters, body composition, and progression of disability in older disabled residents living in nursing homes. JGeront A Biol Sci Med Sci 2001, 56:M212-M216.
83. Morley J.E., Thomas D.R., Wilson M.M. Cachexia: Pathophysiology and clinical relevance. Am J Clin Nutr 2006, 83:735-743.
84. Thomas D.R. Loss of skeletal muscle mass in aging: Examining the relationship of starvation, sarcopenia, and cachexia. Clin Nutr 2007, 26:389-399.
85. McGandy R.B., Barrows C.H., Spanias A., et al. Nutrient intake and energyexpenditure in men of different ages. JGeron Med Sci 1966, 21:581-587.
86. Abraham S., Carroll M.D., Dresser C.M., et al. Dietary intake of persons 1-74 years of age in the United States. Advance Data from Vital and Health Statistics of the National Center for Health Statistics No. G 1977, Public Health Service, Rockville, MD.
87. Morley J.E., Thomas D.R. Anorexia and aging: Pathophysiology. Nutrition 1999, 15:499-503.
88. Kendrick Z.V., Nelson-Steen S., Scafidi K. Exercise, aging, and nutrition. Southern Med J 1994, 87:S50-S60.
89. Lipson L.G., Bray G.A. Energy. Nutritional Aspects of Aging 1986, CRC Press, Cleveland, OH. L.H. Chen (Ed.).
90. Poehlman E.T., McAuliffe T.L., Van Houten D.R., Danforth E. Influence of age and endurance training on metabolic rate and hormones in healthy men. Am J Physiol 1990, 259:E66-E72.
91. Aniansson A., Sperling L., Rundgren A., Lehnberg E. Muscle function in 75 year old men and women: A longitudinal study. Scand J Rehab Med 1983, 9:92-102.
92. Davies C., Thomas D., White M. Mechanical properties of young and elderly human muscle. Acta Med Scand Suppl 1985, 711:219-226.
93. Larron L., Grimby G., Karlsson J. Muscle strength and speed of movement in relation to age and muscle morphology. JAppl Physiol 1979, 46:451-456.
94. Westerterp K.R., Meijer E.P. Physical activity and parameters of aging: A physiological perspective. JGeront Med Sci 2001, 56:7-12.
95. Westerterp K.R. Alterations in energy balance with exercise. Am J Clin Nutr 1998, 68:970S-974S.
96. Thomas D.R. Distinguishing starvation from cachexia. Ger Clin N Am 2002, 18:883-892.
97. Kimmel P.L., Phillips T.M., Simmens S.J., et al. Immunologic function and survival in hemodialysis patients. Kidney Int 1998, 54:236-244.
98. Maltoni M., Fabbri L., Nanni O., et al. Serum levels of tumor necrosis factor alpha and other cytokines do not correlate with weight loss and anorexia in cancer patients. Support Care Cancer 1997, 5:130-135.
99. Visser M., Pahor M., Taaffe D.R., et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: The Health ABC Study. JGerontol A Biol Sci Med Sci 2002, 57:M326-M332.
100. Anker S.D., Ponikowski P.P., Clark A.L., et al. Cytokines and neuro-hormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J 1999, 20:683-693.
101. Schols A.M., Buurman W.A., Staal van den Brekel A.J., et al. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996, 51:819-824.
102. Jensen G., Mirtallo J., Compher C., et al. Adult starvation and disease-related malnutrition: A proposal for etiology-based diagnosis in the clinical practice setting from the International Consensus Guideline Committee. JParen Enteral Nutr 2010, 34:156-159.
103. Espat N.J., Moldawer L.L., Copeland E.M. Cytokine-mediated alterations in host metabolism prevent nutritional repletion in cachectic cancer patients. JSurg Oncol 1995, 58:77-82.
104. Plata-Salaman C.R. Anorexia during acute and chronic disease. Nutrition 1996, 12:69-76.
105. Hedlund J., Hansson L.O., Ortqvist A. Short- and long-term prognosis for middle-aged and elderly patients hospitalized with community-acquired pneumonia: Impact of nutritional and inflammatory factors. Scan J Inf Dis 1995, 27:32-37.
106. Morley J.E. Decreased food intake with aging. JGerontol Med Sci 2001, 56:81-88.
107. Rote N.S. Inflammation. Pathophysiology: The biological basis for disease in adults and children 1998, 205-236. Mosby, St. Louis. K.L. McCance, S.E. Huether (Eds.).
108. Thomas D.R. Guidelines for the use of orexigenic drugs in long term care. Nutr Clin Pract 2006, 21:82-87.
109. Mathey M.R.A.M., Siebelink E., de Graaf C., Van Staveren W.A. Flavor enhancement of food improves dietary intake and nutritional status of elderly nursing home residents. JGerontol Med Sci 2001, 56:M200-M205.
110. Baumgartner R.N., Waters D.L., Gallagher D., et al. Predictors of skeletal muscle mass in elderly men and women. Mech Ageing Dev 1999, 107:123-136.
111. Baumgartner R.N., Koehler K.M., Gallagher D., et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998, 147:755-763.
112. Tzankoff S.P., Norris A.H. Longitudinal changes in basal metabolism in man. JAppl Physiol 1978, 45:536-539.
113. Hughes V.A., Frontera W.R., Roubenoff R., et al. Longitudinal changes in body composition in older men and women: Role of body weight change and physical activity. Am J Clin Nutr 2002, 76:473-481.
114. Evans W. Functional and metabolic consequences of sarcopenia. JNutr 1997, 127:998S-1003S.
115. Brown M., Hasser E.M. Complexity of age-related change in skeletal muscle. JGerontol A Biol Sci Med Sci 1996, 51:B117-B123.
116. Morley J.E., Baumgartner R.N., Roubenoff R., et al. Sarcopenia. JLab Clin Med 2001, 137:231-243.
117. Rosenberg I.H. Sarcopenia: Origins and clinical relevance. JNutr 1997, 127:990S-991S.
118. Aniansson A., Grimby G., Rundgren A. Isometric and isokinetic quadriceps muscle strength in 70-year-old men and women. Scand J Rehabil Med 1980, 12:161-168.
119. Astrand I., Astrand P.O., Hallback I., Kilbom A. Reduction in maximal oxygen uptake with age. JAppl Physiol 1973, 35:649-654.
120. Fleg J.L., Lakatta E.G. Loss of muscle mass is a major determinant of the age-related decline in maximal aerobic capacity. Circulation 1985, 72:64.
121. Jette A.M., Branch L.G. Impairment and disability in the aged. JChronic Dis 1985, 38:59-65.
122. Landi F., Liperoti R., Fusco D., et al. Sarcopenia and mortality among older nursing home residents. JAm Med Dir Assoc 2013, 13:121-126.
123. Cesari M., Vellas B. Sarcopenia: A novel clinical condition or still a matter for research?. JAm Med Dir Assoc 2012, 13:766-767.
124. Roman D., Karen Mahoney K., Ali Mohamadi A. Sarcopenia: What's in a name?. JAm Med Dir Assoc 2013, 14:80-82.
125. Fielding R.A., Vellas B., Evans W.J., et al. Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International Working Group on Sarcopenia. JAm Med Dir Assoc 2011, 12:249-256.
126. Morley J.E., Abbatecola M.A., Argiles J.M., et al. The Society on Sarcopenia, Cachexia and Wasting Disorders Trialist Workshop Sarcopenia with Limited Mobility: An International Consensus. JAm Med Dir Assoc 2011, 12:403-409.
127. Lee W.J., Liu L.K., Peng L.N., et al. The ILAS Research Group. Comparisons of sarcopenia defined by IWGS and EWGSOP criteria among older people: Results from the I-Lan Longitudinal Aging Study. JAm Med Dir Assoc 2013, 14:528.e1-528.e7.
128. Marton K.I., Sox H.C., Krupp J.R. Involuntary weight loss: Diagnostic and prognostic significance. Ann Intern Med 1981, 95:568-574.
129. Wilson M.M., Vaswani S., Liu D., et al. Prevalence and causes of undernutrition in medical outpatients. Am J Med 1998, 104:56-63.
130. Wilson M.M., Thomas D.R., Rubenstein L.Z., et al. Appetite assessment: Simple appetite questionnaire predicts weight loss in community-dwelling adults and nursing home residents. Am J Clin Nutr 2005, 82:1074-1081.
131. Guigoz Y., Vellas B., Garry P.J. Mini-nutritional assessment: A practical assessment tool for grading the nutritional state of elderly patients. Facts Res Gerontol 1994, 2S:15-59.
132. Beck A.M., Ovesen L., Osler M. The Mini-Nutritional Assessment and the Determine Your Nutritional Health Checklist (NSI Checklist) as predictors of morbidity and mortality in an elderly Danish population. Brit J Nutr 1999, 81:31-36.
133. de Groot L.C., Beck A.M., Schroll M., van Staveren W.A. Evaluating the DETERMINE Your Nutritional Health Checklist and the Mini Nutritional Assessment as tools to identify nutritional problems in elderly Europeans. Eur J Clin Nutr 1998, 52:877-883.
134. Kaiser M.J., Bauer J.M., Ramsch C. Validation of the mininutritional assessment short form (MNA-SF): A practical tool for identification of nutritional status. JNutr Health Aging 2009, 11:782-788. The MNA International Group.
135. Huhmann M.B., Perez V., Alexander D.D., Thomas D.R. Aself-completed nutrition screening tool for community-dwelling older adults with high reliability: A comparison study. JNutr Health Aging 2013, 17:339-344.
136. Milne A.C., Potter J., Vivanti A., Avenell A. Protein and energy supplementation in elderly people at risk from malnutrition. Cochrane Database Syst Rev 2009, 2:CD003288.
137. Haddad R.Y., Thomas D.R. Enteral nutrition and enteral tube feeding. Review of the evidence. Clin Geriatr Med 2002, 18:867-881.
138. Dy S.M. Enteral and parenteral nutrition in terminally ill cancer patients: A review of the literature. Am J Hospic Pall Med 2006, 23:369-377.
139. Mitchell S.L., Kiely D.K., Lipsitz L.A. The risk factors and impact on survival of feeding tube placement in nursing home residents with severe cognitive impairment. Arch Intern Med 1997, 157:327-332.
140. Haddad R.Y., Thomas D.R. Enteral nutrition and tube feeding: A review of the evidence. Ger Clin N Am 2002, 18:867-882.
141. Howard L., Ashley C. Nutrition in the perioperative patient. Ann Rev Nutr 2003, 23:263-282.
142. Campos A.C.L., Meguid M.M. Acritical appraisal of the usefulness of perioperative nutritional support. Am J Clin Nutr 1992, 55:117-130.
143. Thomas D.R. Aprospective, randomized clinical study of adjunctive peripheral parenteral nutrition in adult subacute care patients. JNutr Hlth Aging 2005, 9:321-325.
144. Parise G., Yarasheski K.E. The utility of resistance exercise training and aminoacid supplementation for reversing age associated decrements in muscle protein mass and function. Curr Opin Clin Nutr Metab Care 2000, 3:489-495.
145. Liu C.J., Latham N.K. Progressive resistance strength training for improving physical function in older adults. Cochrane Database Syst Rev 2009, 4:CD002759.
146. Malafarina V., Uriz-Otano F., Iniesta R., Gil-Guerrero L. Effectiveness of nutritional supplementation on muscle mass in treatment of sarcopenia in old age: A Systematic Review. JAm Med Dir Assoc 2013, 14:10-17.
147. Paddon-Jones D., Sheffield-Moore M., Creson D.L., et al. Hypercortisolemia alters muscle protein anabolism following ingestion of essential amino acids. Am J Physiol Endocrinol Metabol 2003, 284:E946-E953.
148. Pascual L.A., Roque F.M., Urrutia C.G., et al. Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome. JPain Symp Man 2004, 27:360-369.
149. Gordon J.N., Trebble T.M., Ellis R.D., et al. Thalidomide in the treatment of cancer cachexia: A randomised placebo controlled trial. Gut 2005, 54:540-545.
150. Dewey A., Baughan C., Dean T.P., et al. Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia. Cochrane Pain, Palliative and Supportive Care Group. Cochrane Database of Systematic Reviews 2009, 1. 00075320-100000000-03638.
151. Gordon J.N., Green S.R., Goggin P.M. Cancer cachexia. Quart J Med 2005, 98:779-788.
152. Feldman H.A., Longcope C., Derby C.A., et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: Longitudinal results from the Massachusetts Male Aging Study. JClin Endocrinol Metab 2002, 87:589-598.
153. Page S.T., Amory J.K., Bowman E.D., et al. Exogenous testosterone alone or with finasteride increase physical performance, grip, strength, and lean body mass in older men with low serum testosterone. JClin Endocrinol Metab 2009, 90:1502-1510.
154. Bassaria S., Coviello A.D., Travison T.G., et al. Adverse events associated with testosterone administration. NEngl J Med 2010, 363:109-122.
155. Borst S.E. Interventions for sarcopenia and muscle weakness in older people. Age Ageing 2004, 33:548-555.
156. Hengge U.R., Baumann M., Maleba R., et al. Oxymetholone promotes weight gain in patients with advance human immunodeficiency virus (HIV-1) infection. Brit J Nutr 1996, 75:129-138.
157. Pengelly C.D. Oxymetholone in the chemotherapy of malignant disease. Curr Med Res Opin 1973, 1:401-406.
158. Zachwieja J.J., Yarasheski K.E. Does growth hormone therapy in conjunction with resistance exercise increase muscle force production and muscle mass in men and women aged 60 years or older?. Phys Ther 1999, 79:76-82.
159. Schambelan M., Mulligan K., Grunfeld C., et al. Recombinant human growth hormone in patients with HIV-associated wasting: A randomized, placebo-controlled trial. Ann Int Med 1996, 125:873-882.
160. Morley J.E. Pain-"God's megaphone.". JAm Med Dir Assoc 2012, 13:316-318.
161. Kaakalainen S., Brazil K., Akhtar-Danesh N., et al. The evaluation of an interdisciplinary pain protocol in long term care. JAm Med Dir Assoc 2012, 13:664.e1-664.e8.
162. Cohen-Mansfield J., Thein K., Marx M.S., Dakheel-Ali M. What are the barriers to performing nonpharmacological interventions for behavioral symptoms in the nursing home?. JAm Med Dir Assoc 2012, 13:400-405.
163. Zwakhalen S.M., van der Steen J.T., Najim M.D. Which score most likely represents pain on the observational PAINAD pain scale for patients with dementia?. JAm Med Dir Assoc 2012, 13:384-389.
164. Lapane K.L., Quilliam B.J., Chow W., Kim M. The association between pain and measures of well-being among nursing home residents. JAm Med Dir Assoc 2012, 13:344-349.
165. Azoulay D., Jacobs J.M., Cialic R., et al. Opioids, survival, and advanced cancer in the hospice setting. JAm Med Dir Assoc 2011, 12:129-134.
166. Woo J., Cheng J.O., Lee J., et al. Evaluation of a continuous quality improvement initiative for end-of-life care for older noncancer patients. JAm Med Dir Assoc 2011, 12:105-113.
167. Carlson M.D., Lim B., Meier D.E. Strategies and innovative models for delivering palliative care in nursing homes. JAm Med Dir Assoc 2011, 12:91-98.
168. Hanlon J.T., Perera S., Sevick M.A., et al. Pain and its treatment in older nursing home hospice/palliative care residents. JAm Med Dir Assoc 2010, 11:579-583.
169. Cervo F.A., Bruckenthal P., Chen J.J., et al. Pain assessment in nursing home residents with dementia: Psychometric properties and clinical utility of the CAN Pain Assessment Tool (CPAT). JAm Med Dir Assoc 2009, 10:505-510.
170. Husebo B.S., Strand L.I., Moe-Nilssen R., et al. Who suffers most? Dementia and pain in nursing home patients: A cross-sectional study. JAm Med Dir Assoc 2008, 9:427-433.
171. Tait R.C., Chibnall J.T. Under-treatment of pain in dementia: Assessment is key. JAm Med Dir Assoc 2008, 9:372-374.
172. Sawyer P., Lillis J.P., Bodner E.V., Allman R.M. Substantial daily pain among nursing home residents. JAm Med Dir Assoc 2007, 8:158-165.
173. Cipher D.J., Clifford P.A., Roper K.D. Behavioral manifestations of pain in the demented elderly. JAm Med Dir Assoc 2006, 7:355-365.
174. Lukas A., Mayer B., Fialova D., et al. Treatment of pain in European nursing homes: Results from the Services and Health for Elderly in Long TERm care (SHELTER) study. JAm Med Dir Assoc 2013, 14:821-831.
175. Lukas A., Mayer B., Fialova D., et al. Pain characteristics and pain control in European nursing homes: Cross-sectional and longitudinal results from the services and health for elderly in long term care (SHELTER) study. JAm Med Dir Assoc 2013, 14:421-428.
176. Vandervoort A., Van den Block L., van der Steen J.T., et al. Nursing home residents dying with dementia in Flanders, Belgium: A nationwide postmortem study on clinical characteristics and quality of dying. JAm Med Dir Assoc 2013, 14:485-492.
177. Takai Y., Yamamoto-Mitani N., Chiba Y., et al. Prevalence of pain among residents in Japanese nursing homes: A descriptive study. Pain Manag Nurs 2013, 14:e1-e9.
178. Landmark B.T., Gran S.V., Kim H.S. Pain and persistent pain in nursing home residents in Norway. Res Gerontol Nurs 2013, 6:47-56.
179. van Kollenberg E.G., Lavrijsen J.C., Verhagen S.C., et al. Prevalence, causes and treatment of neuropathic pain in Dutch nursing home residents: A retrospective chart review. JAm Geriatr Soc 2012, 60:1418-1425.
180. Ahn H., Horgas A. The relationship between pain and disruptive behaviors in nursing home resident with dementia. BMC Geriatr 2013, 13:14.
181. Morley J.E. Clinical practice in nursing homes as a key for progress. JNutr Health Aging 2010, 14:586-593.
182. Kamel H.K., Phlavan M., Malekgoudarzi B., et al. Utilizing pain assessment scales increases the frequency of diagnosing pain among elderly nursing home residents. JPain Symptom Manage 2001, 21:450-455.
183. Rastogi R., Meek B.D. Management of chronic pain in elderly, frail patients: Finding a suitable, personalized method of control. Clinical Interventions in Aging 2013, 8:37-46.
184. Morley J.E., Vellas B., van Kan G.A., et al. Frailty consensus: A call to action. JAm Med Dir Assoc 2013, 14:392-397.
185. Morley J.E. Anabolic steroids and frailty. JAm Med Dir Assoc 2010, 11:533-536.
186. Morley J.E. Frailty: Diagnosis and management. JNutr Health Aging 2011, 15:667-670.
187. Morley J.E. Developing novel therapeutic approaches to frailty. Curr Pharm Des 2009, 15:3384-3395.
188. Declaration of Montreal: Declaration that access to pain management is a fundamental human right. JPain Palliat Care Pharmacother 2011, 25:29-31. International Pain Summit of the International Association for the Study of Pain.
189. Saliba D., Jones M., Streim J., et al. Overview of significant changes in the Minimum Data Set for nursing homes version 3.0. JAm Med Dir Assoc 2012, 13:595-601.
190. Saliba D., Buchanan J. Making the investment count: Revision in the Minimum Data Set for nursing homes, MDS 3.0. JAm Med Dir Assoc 2012, 13:602-610.
191. Onen S.H., Onen F., Albrand G., et al. Pain tolerance and obstructive sleep apnea in the elderly. JAm Med Dir Assoc 2010, 11:612-616.
192. Morley G.K., Mooradian A.D., Levine A.S., Morley J.E. Mechanism of pain in diabetic peripheral neuropathy. Effect of glucose on pain perception in humans. Am J Med 1984, 77:79-82.
193. Sinclair A., Morley J.E., Rodriguez-Mañas L., et al. Diabetes mellitus in older people: Position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. JAm Med Dir Assoc 2012, 13:497-502.
194. Pautex S., Cedraschi C., Allaz A.F. Characteristics of elderly patients with fibromyalgia: A pilot retrospective study. Aging Clin Exp Res 2012, 24:490-494.
195. Morley J.E. Transitions. JAm Med Dir Assoc 2010, 11:607-611.
196. Gruneir A., Anderson G.M., Rochon P.A., Bronskill S. Transitions in long term care and potential implications for quality reporting in Ontario, Canada. JAm Med Dir Assoc 2010, 11:629-635.
197. Wong R.Y. Improving health care transitions for older adults through the lens of quality improvement. JAm Med Dir Assoc 2013, 14:637-638.
198. Terrell K.M., Miller D.K. Strategies to improve care transitions between nursing homes and emergency departments. JAm Med Dir Assoc 2011, 12:602-605.
199. Lett J.E. AMDA national engagement in care transitions. JAm Med Dir Assoc 2011, 12:387.
200. Tolson D., Loundes A., Booth J., et al. The potential of communities of practice to promote evidence-informed practice within nursing homes. JAm Med Dir Assoc 2011, 12:169-173.
201. Foulkes T., Wood J.N. Pain genes. PLoS Genet 2008, 4:e1000086.
202. Nielson CS, Stubhaug A, Price DD, etal. Individual differences in pain sensitivity: Genetic and environmental contributions. Pain 136:21-29.
203. Klement W., Arndt J.O. The role of noriceptors of cutaneous veins in the mediation of cold pain in man. JPhysiol 1992, 449:73-83.
204. Kato K., Sullivan P.F., Evengard B., Pedersen N.L. Importance of genetic influences on chronic widespread pain. Arthritis Rheum 2006, 54:1682-1686.
205. Zubieta J.K., Heitzeg M.M., Smith Y.R., et al. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 2003, 299:1240-1243.
206. Fillingim R.B., Kaplan L., Staud R., et al. The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRMI) is associated with pressure pain sensitivity in humans. JPain 2005, 6:159-167.
207. Tegeder I., Costigan M., Griffin R.S., et al. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med 2006, 12:1269-1277.
208. Kim H., Mittal D.P., Iadarola M.J., Dionne R.A. Genetic predictors for acuteexperimental cold and heat pain sensitivity in humans. JMed Genet 2006, 43:e40.
209. Morley J.E. Dementia-related agitation. JAm Med Dir Assoc 2011, 12:611-612.e2.
210. Caspi E. Time for change: Persons with dementia and "behavioral expressions," not "behavior symptoms.". JAm Med Dir Assoc 2013, 14:768-769.
211. Morgan D.G., Cammer A., Stewart N.J., et al. Nursing aide reports of combative behavior by residents with dementia: Results from a detailed prospective incident diary. JAm Med Dir Assoc 2012, 13:220-227.
212. Volicer L. Is your nursing home a battlefield?. JAm Med Dir Assoc 2012, 13:195-196.
213. Fauth EB, Gibbons A. Which behavioral and psychological symptoms of dementia are the most problematic? Variability by prevalence, intensity, distress ratings, and associations with caregiver depressive symptoms [published online ahead of print 12 July 2013]. Int J Geriatr Psychiatry http://dx.doi.org/10.1002/gps.4002.
214. Nakanishi M., Hattori K., Nakashima T., Sawamura K. Priority for elderly persons with behavioral and psychological symptoms of dementia on waiting lists for placement in nursing homes in Japan: Do nursing homes change priorities based on their own guidelines?. JAm Med Dir Assoc 2012, 13:794-799.
215. Zahodne L.B., Ornstein K., Cosentino S., et al. Longitudinal relationships between Alzheimer disease progression and psychosis, depressed mood, and agitation/aggression. Am J Geriatr Psychiatry 2013, Pii:S1064-7481(13)00201-7 [Epub ahead of print].
216. Hölttä E.H., Laakkonen M.L., Laurila J.V., et al. Apathy: Prevalence, associated factors, and prognostic value among frail, older inpatients. JAm Med Dir Assoc 2012, 13:541-545.
217. Morley J.E. Behavioral management in the person with dementia. JNutr Health Aging 2013, 17:35-38.
218. Morley J.E. Editorial: Can we improve care for patients with dementia?. JNutr Health Aging 2011, 15:523-525.
219. Morley J.E. Alzheimer's disease: Future treatments. JAm Med Dir Assoc 2011, 12:1-7.
220. Oustric S., Rouge-Bugat M.E., Vellas B. Primary care practitioners on thefrontline of Alzheimer's disease care. JAm Med Dir Assoc 2011, 12:545-546.e1.
221. Wijeyesinghe A., Madan R.I. Managing apathy. JAm Med Dir Assoc 2011, 12:554-555.
222. Volicer L., Frijters D.H., van der Steen J.T. Apathy and weight loss in nursinghome residents: Longitudinal study. JAm Med Dir Assoc 2013, 14:417-420.
223. Irvine A.B., Billow M.B., Bourgeois M., Seeley J.R. Mental illness training for long term care staff. JAm Med Dir Assoc 2012, 13:81.e7-81.e13.
224. Jeon Y.H., Govett J., Low L.F., et al. Care planning practices for behavioural and psychological symptoms of dementia (BPSD) in residential aged care: A pilot of an education toolkit informed by the Aged Care Funding Instrument (ACFI). Contemp Nurse 2013, 44:156-169.
225. Spector A., Orrell M., Goyder J. Asystematic review of staff training interventions to reduce the behavioural and psychological symptoms of dementia. Ageing Res Rev 2013, 12:354-364.
226. Tolson D., Lowndes A., Booth J., et al. The potential of communities of practice to promote evidence-informed practice within nursing homes. JAm Med Dir Assoc 2011, 12:169-173.
227. Rapp M.A., Mell T., Majic T., et al. Agitation in nursing home residents with dementia (VIDEANT Trial): Effects of a cluster-randomized, controlled, guideline implementation trial. JAm Med Dir Assoc 2013, 14:690-695.
228. Toba K., Nakamura Y., Endo H., et al. Intensive rehabilitation for dementia improved cognitive function and reduced behavioral disturbance in geriatric health service facilities in Japan. Geriatr Gerontol Int 2013, [Epub ahead of print]. 10.1111/ggi.12080.
229. Seitz D.P., Brisbin S., Herrmann N., et al. Efficacy and feasibility of nonpharmacological interventions for neuropsychiatric symptoms of dementia in long term care: A systematic review. JAm Med Dir Assoc 2012, 13:503-506.e2.
230. Thune-Boyle IC, Iliffe S, Cerga-Pashoja A, etal. The effect of exercise on behavioral and psychological symptoms of dementia: Towards a research agenda.
231. Aman E., Thomas D.R. Supervised exercise to reduce agitation in severely cognitively impaired persons. JAm Med Dir Assoc 2009, 10:271-276.
232. Morley J.E. Managing persons with dementia in the nursing home: High touch trumps high tech. JAm Med Dir Assoc 2008, 9:139-146.
233. Majic T., Gutzmann H., Heinz A., et al. Animal-assisted therapy and agitation and depression in nursing home residents with dementia: A matched case-control trial. Am J Geriatr Psychiatry 2013, 21:1054-1059.
234. Robinson H., MacDonald B., Kerse N., Broadbent E. The psychosocial effects of a companion robot: A randomized controlled trial. JAm Med Dir Assoc 2013, 14:661-667.
235. Robinson H., MacDonald B.A., Kerse N. Broadbent. Suitability of healthcare robots for a dementia unit and suggested improvements. JAm Med Dir Assoc 2013, 14:34-40.
236. Fung J.K., Tsang H.W., Chung R.C. Asystematic review of the use of aromatherapy in treatment of behavioral problems in dementia. Geriatr Gerontol Int 2012, 12:372-382.
237. Van Bogaert P., Van Grinsven R., Tolson D., et al. Effects of SolCos model-based individual reminiscence on older adults with mild to moderate dementia dueto Alzheimer disease: A pilot study. JAm Med Dir Assoc 2013, 14:528.e9-528.e13.
238. Ueda T., Suzukamo Y., Sato M., Izumi S. Effects of music therapy on behavioral and psychological symptoms of dementia: A systematic review and meta-analysis. Ageing Res Rev 2013, 12:628-641.
239. Spector A., Orrell M., Hall L. Systematic review of neuropsychological outcomes in dementia from cognition-based psychological interventions. Dement Geriatr Cogn Disord 2012, 34:244-255.
240. Tolson D., Morley J.E., Rolland Y., Vellas B. Advancing nursing home practice: The International Association of Geriatrics and Gerontology recommendations. Geriatr Nurs 2011, 32:195-197.
241. Henry G., Williamson D., Tampi R.R. Efficacy and tolerability of antidepressants in the treatment of behavioral and psychological symptoms of dementia, a literature review of evidence. Am J Alzheimer Dis Other Demen 2011, 26:169-183.
242. Cornege-Blokland E., Kleijer B.C., Hertogh C.M., van Marum R.J. Reasons to prescribe antipsychotics for the behavioral symptoms of dementia: A survey in Dutch nursing homes among physicians, nurses, and family caregivers. JAm Med Dir Assoc 2012, 13:80.e1-80.e6.
243. Jennings L., Grossberg G.T. Antipsychotics continue to have a place in the management of difficult behavior problems in patients with dementia. JAm Med Dir Assoc 2013, 14:447-449.
244. Cheung G., Stapelberg J. Quetiapine for the treatment of behavioural and psychological symptoms of dementia (BPSD): A meta-analysis of randomized placebo-controlled trials. NZ Med J 2011, 124:39-50.
245. Azermai M., Petrovic M., Elseviers M.M., et al. Systematic appraisal of dementia guidelines for the management of behavioural and psychological symptoms. Ageing Res Rev 2012, 11:78-86.
246. Blazer D.G. Antipsychotocs and dementia: Where do we go from here?. JAm Med Dir Assoc 2013, 14:307-308.
247. Morley J.E. Antipsychotics and dementia: A time for restraint?. JAm Med Dir Assoc 2012, 13:761-763.
248. Tolson D., Morley J.E. Physical restraints: Abusive and harmful. JAm Med Dir Assoc 2012, 13:311-313.
249. Valencia I.C., Falabella A., Kirsner R.S., et al. Chronic venous insufficiency and venous leg ulceration. Am Acad Dermatol 2001, 44:401-421.
250. de Araujo T., Valencia I., Federman D.G., et al. Managing the patient with venous ulcers. Ann Intern Med 2003, 138:326-334.
251. Johnson B.F., Manzo R.A., Bergelin R.O., Strandness D.E. Relationship between changes I in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein thrombosis: a one- to sixyear follow-up. J Vasc Surg 1995, 21:307-312.
252. Raju S., Neglén P. High prevalence of nonthrombotic iliac vein lesions in chronic venous disease: a permissive role in pathogenicity. J Vasc Surg 2006, 44:136-143.
253. Neglén P., Raju S. A rational approach to detection of significant reflux with duplex Doppler scanning and air plethysmography. J Vasc Surg 1993, 17:590-595.
254. Pappas P.J., Lal B.K., Ohara N., Saito S., Zapiach L., Durán W.N. Regulation of matrix contraction in CVI patients. Eur J Endovasc Surg 2009, 38:518-529.
255. Bergan J.J., Schmid-Schonbein G.W., Smith P.D., Nicolaides A.N., Boisseau M.R., Eklof B. Chronic venous disease. N Engl J Med 2006, 355:488-498.
256. Barron G.S., Jacob S.E., Kirsner R.S. Dermatologic complications of chronic venous disease: medical management and beyond. Ann Vasc Surg 2007, 21:652-662.
257. Raju S., Owen S., Neglén P. Reversal of abnormal lymphoscintigraphy after placement of venous stents for correction of associated venous obstruction. J Vasc Surg 2001, 34:779-784.
258. Mekkes J.R., Loots M.A., Van Der Wal A.C., Bos J.D. Causes, investigation and treatment of leg ulceration. Br J Dermatol 2003, 148:388-401.
259. Dissemond D., Körber A., Grabbe S. Differential diagnosis of leg ulcers. JDDG 2006, 4:627-634.
260. De Araujo T.S., Hexsel C.L., Kirsner R.S. Treatment of venous ulcers. Curr Treat Options Cardiovasc Med 2005, 7:131-138.
261. Margolis D.J., Berlin J.A., Strom B.L. Which venous leg ulcers will heal with limb compression bandages?. Am J Med 2000, 109:15-19.
262. Kurz N, Kahn SR, Abenhaim L, et al., eds. VEINES Task Force Report: The management of chronic venous disorders of the leg (CVDL): an evidence-based report of an international task force. McGill University. Sir Mortimer B. Davis-Jewish General Hospital. Summary reports in: Angiology. 1997;48(1):59-66; and Int Angiol. 1999;18(2):83-102.
263. Kurz N, Kahn SR, Abenhaim L, et al., eds. VEINES Task Force Report: The management of chronic venous disorders of the leg (CVDL): an evidence-based report of an international task force. McGill University. Sir Mortimer B. Davis-Jewish General Hospital. Summary reports in: Int Angiol. 1999;18(2):83-102.
264. Heit J.A. Venous thromboembolism epidemiology: implications for prevention and management. Semin Thromb Hemost 2002, 28(suppl 2):3-13.
265. Chan C.L.H., Meyer F.J., Hay R.J., et al. Toe ulceration associated with compression bandaging: observational study. BMJ 2001, 323:1099.
266. O'Meara S., Cullum N.A., Nelson E.A. Compression for venous leg ulcers. Cochrane Database Syst Rev 2009, Issue 1. Art. No.: CD000265, CD000265.pub2. 10.1002/14651858.
267. O'Meara S., Tierney J., Cullum N., et al. Four layer bandage compared with short stretch bandage for venous leg ulcers: systematic review and meta-analysis of randomized controlled trials with data from individual patients. Br Med J 2009, 338:b1344.
268. Nikolovska S., Pavlova L.J., Petrova N., Gocev G. The efficacy of intermittent pneumatic compression in the treatment of venous leg ulcers. Macedonia Medical Review 2002, 5:56-59.
269. Nelson E.A., Mani R., Thomas K., Vowden K. Intermittent pneumatic compression for treating venous leg ulcers. Cochrane Database of Systematic Reviews 2011, Issue 2. Art. No.: CD001899, CD001899.pub3. 10.1002/14651858.
270. Palfreyman S.S.J., Nelson E.A., Lochiel R., Michaels J.A. Dressings for healingvenous leg ulcers. Cochrane Database ofSystematic Reviews 2006, Issue 3. Art. No.: CD001103, CD001103.pub2. 10.1002/14651858.
271. O'Meara S., Al-Kurdi D., Ovington L.G. Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev 2008, 23:CD003557.
272. O'Meara S., Al-Kurdi D., Ologun Y., Ovington L.G. Antibiotics and antiseptics for venous leg ulcers. Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No.: CD003557, CD003557.pub3. 10.1002/14651858.
273. Morias J., Peremans W., Campaert H., Mertens R.L. Levamisole treatment in ulcus cruris. A double-blind placebo-controlled trial. Arzneimittel-Forschung 1979, 29(7):1050-1052.
274. Michaels J.A., Campbell B., King B., et al. Randomized controlled trial and cost-effectiveness analysis of silver-donating antimicrobial dressings for venous leg ulcers (VULCAN trial). Br J Surg 2009, 96:1147-1156.
275. Chambers H., Dumville J.C., Cullum N. Silver treatments for leg ulcers: a systematic review. Wound Repair Regen 2007, 15:165-173.
276. Wieman T.J. Efficacy and safety of recombinant human platelet-derived growth factor-BB (Becaplermin) in patients with chronic venous ulcers: a pilot study. Wounds 2003, 15:257-264.
277. (2008). Accessed Sept 29, 2013. http://www.regranex.com/REGRANEX_DHP_Letter.pdf.
278. Jones J.E., Nelson E.A. Skin grafting for venous leg ulcers. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: CD001737, CD001737.pub3. 10.1002/14651858.
279. Barber C., Watt A., Pham C., et al. Influence of bioengineered skin substitutes on diabetic foot ulcer and venous leg ulcer outcomes. Journal of Wound Care 2008, 17:517-527.
280. Barwell J.R., Davies C.E., Deacon J., et al. Comparison of surgery and compression with compression alone in chronic venous ulceration (ESCHAR study): randomized controlled trial. Lancet 2004, 363:1854-1859.
281. Abisi S., Tan J., Burnand K.G. Excision and meshed skin grafting for leg ulcers resistant to compression therapy. Br J Surg 2007, 94:194-197.
282. Jennette J.C., Falk R.J., Andrassy K., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994, 37:187-192.
283. Wounds UK (2002) Best practice statement. Compression hosiery. Wounds UK. Accessed Sept 30, 2013. http://www.wounds-uk.com/.